Tetrahydrocurcumin derivatives
Tetrahydrocurcumin derivatives with specific substituents address the low solubility issue, enhancing absorption and safety in oral and aqueous formulations, offering improved therapeutic efficacy for diseases such as neurodegenerative diseases and tumors.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- FUKUOKA UNIV
- Filing Date
- 2024-11-14
- Publication Date
- 2026-05-26
AI Technical Summary
Tetrahydrocurcumin exhibits low water solubility, leading to poor absorption during oral administration and requiring large amounts of solubilizers, which can be toxic and increase dosage form burden, and its use in aqueous formulations poses risks of anaphylactic shock.
Development of tetrahydrocurcumin derivatives with specific substituents on phenolic hydroxyl groups to enhance water solubility, allowing for improved absorption and administration in aqueous formulations without the need for solubilizers.
The derivatives exhibit excellent water solubility and enhanced absorption, achieving higher plasma levels and effective bioavailability, with improved safety and efficacy in treating conditions like neurodegenerative diseases, tumors, and inflammation.
Smart Images

Figure 2026086079000001_ABST